complex skin and soft tissue infections | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 405,913 条关于 “complex skin and soft tissue infections”

MicuRx's MRX-4 Meets Primary Endpoint in Phase III cSSTI Trial

Pembrolizumab Plus Radiation and Surgery Improves Outcomes in Stage III Soft-Tissue Sarcoma

Sun Pharma and Philogen Complete Enrollment for Pivotal Phase III FIBROSARC Trial in Soft Tissue Sarcoma

Pembrolizumab Improves Disease-Free Survival in Soft Tissue Sarcoma Patients

Trabectedin-Olaparib Combination Shows Promise for Advanced Soft Tissue Sarcoma Subgroups

Immutep Refocuses Eftilagimod Alfa Development on HNSCC With CPS <1 and Neoadjuvant Soft Tissue Sarcoma

YAP1 and KRAS Identified as Key Drivers in Soft Tissue Sarcoma Development, Opening New Treatment Avenues

Immutep's Efti Plus Pembrolizumab and Radiotherapy Shows Promise in Soft Tissue Sarcoma

Eftilagimod Alpha Combination Shows Promise in Soft Tissue Sarcoma

Elraglusib Receives FDA Orphan Drug Designation for Soft Tissue Sarcoma

第 1 页，共 4078 页